Earnings Report: IBL Healthcare Ltd. (PSX: IBLHL) today reported Financial Results for the Twelve months ended June 30, 2017

IBL Healthcare Ltd. announced Financial Results for the period ended June 30, 2017.

The company’s Revenue for the period increased by 3 percent in the outgoing year, whereas the Profit after Taxation for the Period increased by 11 percent.

The board has not recommended a Cash Dividend for the year ended June 30, 2017. The board issued no bonus or right shares.

Comparison of Key Financials

Unconsolidated Profit and Loss Account – For the Year Ended

Key Financials

2017

2016

% Change

 

Amounts in PKR ‘000

Revenue

1,189,799

1,156,421

2.89%

Cost of Sales

791,899

773,809

2.34%

GP

397,900

382,612

4.00%

Dist: Cost

147,752

136,726

8.06%

Admin: Expenses

45,621

39,268

16.18%

Operating Profit

253,970

223,059

13.86%

Finance Cost

1,403

2,464

-43.06%

Profit before Taxation

252,567

220,595

14.49%

Taxation

54,149

41,701

29.85%

PAT

198,418

178,894

10.91%

EPS – Basic & diluted

4.04

3.68

9.78%

Company release on Earnings Report can be accessed here.

Posted on: 2017-09-22T10:15:00+05:00